In out-of-left-field news, Warhound emerged from stealth with $ 200M in seed funding to clone and genetically engineer working dogs for the military and emergency responders. The startup comes from Palmer Luckey and Colossal Biosciences CEO Ben Lamm. It plans to biobank DNA from top-performing dogs, clone them, and use gene edits to screen out inherited diseases. Investors include Sequoia, In-Q-Tel, and ARK Invest.
- Company
- Warhound warhound.com
- Round
- Seed
- Amount
- $200M
- Source
- wired.com
- In the newsletter
- No. 307, Pop Goes the Hinge